For DPP-4 inhibitors the position statement focused on their low risk of hypoglycemia and also that it can be given in a large group of subjects, including those with reduced renal function
Sawicka AK, Hartmane D, Lipinska P, Wojtowicz E, Lysiak-Szydlowska W, Olek RA
Effects of incretin-based therapeutic agents including tirzepatide on renal outcomes in patients with type 2 diabetes: a systemic review and meta-analysis
Key takeaways: Carnitine transports fat into mitochondria but is not usually the limiting factor Supplementing carnitine alone shows little benefit in most people Choline helps increase and retain carnitine in muscle tissue Combining choline and carnitine improves fat mobilization Adding caffeine further enhances energy expenditure and fat oxidation If a supplement claims to burn fat with carnitine alone, its likely missing the bigger picture
Because the peptide works specifically on fat tissue without affecting other systems, protocols can be designed purely around fat metabolism optimization without concerns about managing glucose, IGF-1, or growth-related effects
For the research context the article is key for understanding why the amylin + GLP-1 combination makes mechanistic sense